Recent Finacing
Recent Raise
Recludix Pharma is a clinical-stage biotech using a proprietary discovery platform to develop first-in-class SH2 domain inhibitors for inflammatory diseases.
Focus Areas
Recent Investors
Funding round
See the team members at Recludix Pharma.
